Lv1
48 积分 2022-11-19 加入
The Prognostic Impact of Lymph Node Yield Upon Survival in Esophageal Cancer Broken Down by Neoadjuvant Strategy: A Multicenter European Cohort Study
1个月前
已完结
Minimally invasive resection of esophageal leiomyoma: 24 year experience
1个月前
已完结
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial
3个月前
已完结
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial
4个月前
已关闭
Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial
4个月前
已完结
Video-Assisted Thoracic Surgery vs Muscle-Sparing Thoracotomy: Prioritizing Randomized Trial to Assess Complications and Long-Term Survival over Cost Comparisons
4个月前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
4个月前
已完结
Neoadjuvant Concurrent Chemo–Immuno–Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)
4个月前
已完结
Robot-assisted versus thoracoscopic esophagectomy for esophageal cancer: long-term oncological and functional outcomes
5个月前
已关闭
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial
5个月前
已完结
皖公网安备34019202002308
